1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Refractory or Relapsed Multiple Myeloma: new trials by email Literature Review of Refractory or Relapsed Multiple Myeloma trials Research Report on Refractory or Relapsed Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma CAR-BCMA T cells, Fludarabine, Cyclophosphamide - Refractory or Relapsed Multiple Myeloma | Not applicable | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 6 | 2017-10-13 | 2020-10-12 |
Multiple Myeloma (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Vascular Diseases (1)
Cyclophosphamide (1) · fludarabine (1)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (1)
Siguo Hao, MD (1)